‘Prioritising profit’: Australians regularly prescribed medicinal cannabis with very high THC levels
Researchers from Monash University have raised concerns that Australian doctors are prescribing medicinal cannabis with THC levels significantly higher than those tested in clinical trials. The study highlights a lack of regulatory oversight, as only a small fraction of available products have undergone formal evaluation.
Researchers evaluated the efficacy and safety of higher THC potency medicinal cannabis products, finding that higher-dose products are commonly being prescribed in Australia. Photograph: Matt Hunt/NurPhoto/Shutterstock Researchers evaluated the efficacy and safety of higher THC potency medicinal cannabis products, finding that higher-dose products are commonly being prescribed in Australia. Photograph: Matt Hunt/NurPhoto/Shutterstock Health ‘Prioritising profit’: Australians regularly prescribed medicinal cannabis with very high THC levels Exclusive: Of more than 1,000 medicinal cannabis products available, only two have been evaluated by the drug regulator
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in